Judicial Watch Uncovers FDA Records Detailing 16 New Deaths Tied to Gardasil

/Standard Newswire/ -- Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it has received new documents from the U.S. Food and Drug Administration (FDA) under the provisions of the Freedom of Information Act (FOIA), detailing reports of adverse reactions to the vaccination for human papillomavirus (HPV), Gardasil. The adverse reactions include 16 new deaths (including four suicides) between May 2009 and September 2010. The FDA also produced 789 "serious" reports, with 213 cases resulting in permanent disability and 25 resulting in a diagnosis of Guillian Barre Syndrome.

Adverse report excerpts include:

* A nineteen year old girl with no medical history except occasional cases bronchitis received Gardasil and in 53 days, had "Headache, Nausea, dizziness, chilling, tiredness, shortness of breath, complained of chest plain, severe cramps." She experienced an Acute Cardiac Arrhythmia. Attempts to resuscitate her resulted in a sternal fracture, but were unsuccessful and the patient died. -- V. 356938

* A thirteen year old girl was vaccinated on July 17th, 2009. Ten days later, she developed a fever and was treated. However, "the patient did not recover and was admitted to the hospital on [August 8th]...She developed dyspnoea and went into a coma...she expired [that day] at around 9:00 pm. The cause of death was determined as 'death due to viral fever.' ... This event occurred after 23 days of receiving first dose of Gardasil. -- V. 380081

* Thirteen days after vaccination, a ten year old girl developed "progressive loss of strength in lower and upper extremities almost totally...Nerve conduction studies [showed Guillain Barre Syndrome]." Case was "considered to be immediately life-threatening." -- V. 339375

* One mother of a 13-year old girl who died 37 days after receiving the vaccination noted in a report: "I first declined getting her the vaccination but her doctor ensured me that it was safe..." After her daughter complained of a severe headache, no feeling in her foot and a tingling feeling in her leg, a doctor's appointment was set for October 23, 2009. "My daughter never made it to Oct[ober] 23rd, which is also her birthday," the mother noted. "She passed on Oct[ober] 17th, I found her cold unresponsive in her room at 7am...."

"To say Gardasil has a suspect safety record is a big understatement. These reports are troubling and show that the FDA and other public health authorities may be asleep at the switch," said Judicial Watch President Tom Fitton. "In the meantime, the public relations push for Gardasil by Merck and politicians on Capitol Hill continues. No one should require this vaccine for young children."

In 2008, Judicial Watch launched a comprehensive investigation of Gardasil's safety record. All previous FDA documents uncovered by Judicial Watch, as well as a Judicial Watch special report, entitled "Examining the FDA's HPV Vaccine Records: Detailing the Approval Process, Side-Effects, Safety Concerns & Marketing Practices of a Large Scale Health Experiment," are available at
www.JudicialWatch.org (http://r20.rs6.net/tn.jsp?llr=hl94yxbab&et=1103726832989&s=13633&e=0019k-0tTevIIcuiGvoaAfx-_dDjhrytmKNsMXSa7cx1qOpHEE38bsioz_9OSnd-aZhrS_agrrYNSLxUqcZwuD57S3sJcHV_V_w04pJv06yfKf3xNcIuwQ7Dw==).

-----
Community News You Can Use
Click to read MORE news:
www.GeorgiaFrontPage.com
Twitter: @gafrontpage & @TheGATable @HookedonHistory
www.ArtsAcrossGeorgia.com
Twitter: @artsacrossga, @softnblue, @RimbomboAAG
www.FayetteFrontPage.com
Twitter: @FayetteFP

HPV Vaccine Study Shows Why Few Women Getting Shots

TT Note: Gotta admit it. The massive advertising did encourage questions in my mind, but it was advertising.

/PRNewswire/ -- Sales of Merck's HPV vaccine, Gardasil, declined by a third this year, and three years after the FDA approved the drug an estimated three out of four women remain unvaccinated -- despite millions spent on advertising and lobbying for government mandates. A recent marketing study offers a reason.

Michelle Steward, assistant professor of marketing at Wake Forest University, and several colleagues conducted an experiment with women, ages 18 to 30, and found that they were more likely to consider being vaccinated for HPV after participating in a survey than as a result of commercial advertising or a government mandate.

"The educational cues in the survey are the least coercive and appear to prompt more thinking about the risks of not being vaccinated than laws, which may produce a negative backlash or advertisements, of which consumers might be skeptical," said Steward.

"The results would suggest that Merck's money may be best spent engaging people through a survey on relevant health topics to get the consumer to think about their own risks. There's nothing to suggest that there would be any difference in males' reactions. If Merck gains FDA approval to market Gardasil for boys, the advantages of surveys versus mandates or advertising would remain the same.

"Determining how best to move consumers from hearing about a drug or vaccination to actually using the product should rival R&D in importance to a firm," Steward said.

The study, "The Influence of Different Types of Cues-to-Action on Vaccination Behavior: An Exploratory Study," will be published in the spring edition of the Journal of Marketing Theory and Practice.

-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page